IMMURON LIMITED Research and Development Expense
IMMURON LIMITED (IMRN) reported Research and Development Expense of AUD 3.60 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-09-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2025-09-25
AUD
| Period end | Research And Development Expense 7 month | Research And Development Expense 12 month |
|---|---|---|
| 2025-06-30 | 3.60M AUD 20-F · filed 2025-09-25 | |
| 2024-06-30 | 5.38M AUD 20-F · filed 2025-09-25 | |
| 2023-06-30 | 221.60K AUD 20-F · filed 2023-09-28 | 2.59M AUD 20-F · filed 2025-09-25 |
| 2022-06-30 | 657.72K AUD 20-F · filed 2024-10-01 | |
| 2021-06-30 | 1.37M AUD 20-F · filed 2023-09-28 | |
| 2020-06-30 | 1.18M AUD 20-F · filed 2022-09-09 | |
| 2019-06-30 | 1.04M AUD 20-F · filed 2021-10-29 | |
| 2018-06-30 | 2.26M AUD 20-F · filed 2020-10-28 | |
| 2017-06-30 | 4.63M AUD 20-F · filed 2019-10-28 | |
| 2016-06-30 | 3.62M AUD 20-F · filed 2018-10-31 |
USD
| Period end | Research And Development Expense 6 month |
|---|---|
| 2023-12-31 | $2.65M 6-K/A · filed 2024-05-28 |
| 2022-12-31 | $1.52M 6-K/A · filed 2024-05-28 |
| 2019-12-31 | $761.42K 6-K/A · filed 2020-06-19 |
| 2018-12-31 | $514.39K 6-K/A · filed 2020-06-19 |